ANMCO-SIC-AIAC guidelines for the appropriate use of permanent cardiac stimulation devices;Linee guida ANMCO-SIC-AIAC sull'uso appropriato delle metodiche di elettrostimolazione cardiaca definitiva

Italian Heart Journal Supplement

Volumn 1, Issue 4, 2000, Pages 551-568

  Zoni Berisso, M ^a   Bongiorni, M G ^a   Della Bella, P ^a   Proclemer, A ^a   Viani, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOMYOPATHY; CLINICAL PRACTICE; ELECTROSTIMULATION; HEART ATRIUM FLUTTER; HEART FIBRILLATION; HEART STIMULATION; HUMAN; PRACTICE GUIDELINE; REVIEW; TACHYCARDIA;

ADOLESCENT; ADULT; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; CARDIOLOGY; CHILD; DEFIBRILLATORS, IMPLANTABLE; HUMANS; ITALY; PACEMAKER, ARTIFICIAL; SOCIETIES, MEDICAL; TERMINOLOGY;

EID: 0033710085     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (180)

1. ACC/AHA Guidelines for implantation of cardiac pacemakers and arrhythmias devices. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
2. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
3. Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group
4. Orientamenti sulla valutazione diagnostica dei pazienti con sincope
5. Le aritmie cardiache: Aggiornamento terminologico
6. Survival in sino-atrial disorder (sick-sinus syndrome)
7. Survival and follow-up after pacemaker implantation: A comparison of patients with sick-sinus syndrome, complete heart block and atrial fibrillation
8. Natural history of sinus node disease treated with atrial pacing in 213 patients: Implications for selection of stimulation mode
9. The sick-sinus syndrome. Natural history of dysfunction of the sino-atrial node
10. Clinical spectrum of the sick-sinus syndrome
11. Cost benefit analysis of single and dual chamber pacing for sick sinus syndrome and atrioventricular block. An economic sensitivity analysis of the literature
12. Relation of prognosis in sick-sinus syndrome to age, conduction defects, and modes of permanent cardiac pacing
13. Effects of permanent pacemaker and oral theophylline in sick-sinus syndrome. The THEOPACE Study: A randomized controlled trial
14. The natural course of untreated sick-sinus syndrome and identification of the variables predictive of unfavorable outcome
15. Arterial thromboembolism in patients with sick-sinus syndrome: Prediction from pacing mode, atrial fibrillation, and echocardiographic findings
16. Stroke and atrial fibrillation in sick-sinus syndrome
17. Twenty-four hour continuous ECG recordings in long-distance runners
18. Arrhythmias associated with sinus node dysfunction. Pathogenesis, recognition and management
19. The sinus node. Structure, function and clinical relevance
20. Chronic atrial fibrillation and stroke in paced patients with sick-sinus syndrome
21. Ventricular pacing for sick-sinus syndrome: A risky business?
22. Chronic sinus node disease: Natural course and indications for pacing
23. Cardiac pacing
24. Documented symptomatic bradycardia and symptom relief in patients receiving permanent pacemakers: An evaluation of the Joint ACC/AHA Pacing Guidelines
25. Pacemaker therapy in patients with atrial fibrillation
26. Indications, effectiveness and long-term dependency in permanent pacing after cardiac surgery
27. Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation
28. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillation
29. Improvement in left ventricular systolic function after successful radiofrequency His-bundle ablation for drug-refractory, chronic atrial fibrillation and recurrent atrial flutter
30. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias
31. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study
32. A prospective hemodynamic evaluation of patients with chronic atrial fi-brillation undergoing radiofrequency catheter ablation of the atrioventricular junction
33. Comparison of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation
34. Assessment of atrioventricular junction ablation and DDDR mode switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study
35. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias
36. Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation
37. Indication for permanent cardiac pacing in first-degree AV block: Class I, II, or III?
38. Newer clinical application of pacing
39. Evolving indication for permanent pacing
40. Effects of dual chamber pacing with short atrioventricular delay in dilated cardiomyopathy
41. Natural history of chronic second-degree atrioventricular nodal block
42. The significance of second degree atrioventricular block and bundle branch block: Observations regarding site and type of block
43. Clinical concepts of spontaneous and induced atrioventricular block
44. Surgical treatment of complete heart block: An analysis of 36 cases
45. Some clinical features of complete heart block
46. Prognostic value of infranodal conduction time in patients with chronic bundle branch block
47. Natural history of high risk bundle branch block: Final report of a prospective study
48. Indications for permanent pacing
49. Atrioventricular and intraventricular conduction disorders in acute myocardial infarction: A reappraisal in the thrombolytic era
50. Risultati generali intra-ospedalieri e follow-up ad un anno
51. Disturbi della conduzione intraventricolare in corso di infarto miocardico acuto: Frequenza di comparsa, significato clinico, indicazioni e ruolo della terapia elettrica
52. Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block
53. Significance of high degree atrioventricular block in acute posterior myocardial infarction
54. The Birmingham trial of permanent pacing in patients with intraventricular conduction disorders after acute myocardial infarction
55. A 5 1/2 year retro and prospective study on early identification of candidates developing late in-hospital ventricular fibrillation
56. A long-term prognosis after acute myocardial infarction with atrio-ventricular block
57. Long-term prognosis in patients with bundle branch block complicating acute anteroseptal infarction
58. Long-term survival of patients with incomplete bundle branch block complicating acute myocardial infarction
59. A simplified method to predict occurrence of complete heart block during acute myocardial infarction
60. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion
61. Influence of right bundle branch block on short- and long-term survival after acute anterior myocardial infarction
62. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction
63. Linee guida alla diagnosi e valutazione delle sincopi mediate dal sistema nervoso autonomo
64. Carotid sinus hypersensitivity and carotid sinus syndrome
65. Carotid sinus syndrome: Diagnosis, natural history and treatment
66. Carotid sinus hypersensitivity: Evaluation of the vasodepressor component
67. Hyperactive carotid sinus reflex and carotid sinus syncope
68. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome
69. Permanent demand pacing for hypersensitive carotid sinus syndrome
70. Pathophysiology of vasovagal syncope
71. Proposed classification for tilt induced vasovagal syncope
72. Permanent pacing for cardioinhibitory malignant vasovagal syncope
73. Cardiac pacing for prevention of recurrent vasovagal syncope
74. The North American Vasovagal Pacemaker Study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
75. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefit of dual-chamber pacing
76. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome
77. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality
78. Cardiac pacing in special and complex situations. Indications and mode of stimulation
79. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick-sinus syndrome
80. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases
81. Antiarrhythmic efficacy of atrial demand (AAI) and rate responsive atrial pacing
82. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
83. Non-pharmcological treatment of supraventricular arrhythmias
84. Electrophysiology, pacing and arrhythmias
85. Pacing in atrial arrhythmias
86. Consistent atrial pacing: Can this new algorithm suppress recurrent paroxysmal atrial fibrillation?
87. Biatrial synchronous pacing for atrial arrhythmia prevention: The SYNBIAPACE study
88. Long-term hemodynamic and antiarrhythmic benefits of DDDR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence
89. Rate augmentation and atrial arrhythmias in DDDR pacing
90. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
91. Atrial tachyarrhythmias associated with high degree interatrial conduction block
92. Interatrial septum pacing: A new approach to prevent paroxysmal atrial fibrillation
93. Atrial septal pacing: A method of pacing the atria simultaneously
94. Functional assessment of patients treated with permanent dual-chamber pacing as a primary treatment for hypertrophic cardiomyopathy
95. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
96. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
97. Cardiomyopathie obstructive du ventricule gauche avec bloc auriculo-ventriculaire complet: Considerations therapeutiques
98. Dual-chamber pacing for hypertrophic obstructive cardiomyopathy: A randomized, double-blind, crossover study
99. Pacing in hypertrophic obstructive cardiomyopathy (PIC): A randomized crossover study
100. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, cross-over study (M-PATHY)
101. Effects of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: Acute Doppler echocardiographic and catheterization hemodynamic study
102. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function
103. DDD pacing in hypertrophic cardiomyopathy: A multicenter clinical experience
104. Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systems
105. Usefulness of physiologic dual chamber pacing in drug resistant idiopathic dilated cardiomyopathy
106. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy
107. Effect of short atrio-ventricular delay on cardiac output
108. Mechanisms of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic study
109. Comparison of atrial contribution to cardiac hemodynamics in patients with normal and severely compromised cardiac function
110. Results of atrio-ventricular synchronous pacing with optimized delay in patients with severe congestive heart failure
111. Hemodynamic benefits of dual-chamber pacing with optimized A-V delay in congestive heart failure: Preliminary results of a randomized study
112. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure
113. Does short A-V delay pacing improve congestive heart failure?
114. What is the role of pacing in dilated cardiomyopathy?
115. Right ventricular outflow tract pacing
116. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output
117. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins
118. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
119. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study
120. Mortality evaluation in the InSync Trial of cardiac resynchronization for heart failure
121. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function
122. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers
123. Sinus node dysfunction after orthotopic cardiac transplantation: Postoperative incidence and long-term implications
124. Sinus node function after cardiac transplantation
125. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy
126. Pacing requirements after orthotopic heart transplantation: Incidence and related factors
127. Sinoatrial function after cardiac transplantation
128. Permanent pacing in heart transplant recipients: Underlying causes and long-term results
129. Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: Association with rejection
130. Bradycardia after heart transplantation: Reversal with theophylline
131. Expanding indications for permanent pacemakers
132. Chronic postsurgical complete heart block with particular reference to prognosis, management and a new P-wave pacemaker
133. Surgical atrioventricular block in 888 congenital heart operations: New implications for early implantation of a permanent pacemaker
134. Early and late postoperative complete heart block in pediatric patients submitted to open-heart surgery for congenital heart disease
135. Problems with permanent atrial pacing in the Fontan patient
136. Incidence and management of dysrhythmias after Fontan procedure
137. Atrial antitachycardia pacing in children and young adults
138. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease
139. Antitachycardia pacemaker treatment of postoperative arrhythmias in pediatric patients
140. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block
141. Isolated congenital complete atrioventricular block in adult life: A prospective study
142. Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block
143. Prophylactic pacing for prevention of sudden death in congenital complete heart block?
144. Congenital complete heart block associated with QT prolongation
145. Congenital complete heart block in patients without anatomic cardiac defects
146. Efficacy of permanent pacing in the management of high risk patients with long QT syndrome
147. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome
148. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome
149. Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: Incidence, clinical features, and long-term evaluation
150. Mode of onset of torsade de pointes in congenital long QT syndrome
151. Prognosis for patients with congenital heart disease and post-operative intraventricular conduction defects
152. Guidelines for implantation of cardiac pacemakers and antiarrhythmic devices. Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Pacemaker Implantation)
153. Implantable cardioverter/defibrillators on cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology
154. Cardiological guidelines. Cardioverter/defibrillator implantation
155. Guidelines for the use of implantable defibrillators. Italian Group of Arrhythmology. Italian Association of Cardiac Pacing Task Force
156. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
157. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia
158. Secondary prevention of sudden death. The DUTCH Study, the Antiarrhythmic Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, the Canadian Implantable Defibrillator Study
159. Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead system. The Pacemaker-Cardioverter-Defibrillator Investigators
160. Unsustained ventricular tachycardia: To treat or not to treat?
161. The MADIT trial: What was wrong?
162. Randomized study of the prevention of sudden death in patients with coronary artery disease
163. Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and implantable cardioverter-defibrillator
164. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: Inducibility and prognostic value in 102 patients
165. Prophylactic use of implantable cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
166. Patterns of catheter ablation practice in the United States: Results of the 1992 NASPE survey
167. Transcatheter electrical ablation of right bundle branch: A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry
168. Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: Results and long-term follow-up
169. Results of electrical fulguration in arrhythmogenic right ventricular disease
170. Radiofrequency catheter ablation of ventricular tachycardia without structural heart disease
171. Navigation in the mega-trials waters: Reflections on the multicenter automatic defibrillator implantation trial and the antiarrhythmics versus implantable defibrillators study
172. Appropriate use of the implantable cardioverter defibrillator: A Canadian perspective
173. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias
174. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors
175. Implantable cardioverter-defibrillator (ICD) indications in 1996: Have they changed?
176. Survival in patients with depressed left ventricular function treated by implantable cardioverter-defibrillator
177. Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome
178. The impact of implantable cardioverter-defibrillator on mortality among patients on the waiting list for heart transplantation